We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App





Artificial Intelligence (AI) Tool Predicts Oxygen Need of Hospitalized COVID-19 Patients Anywhere in the World

By HospiMedica International staff writers
Posted on 16 Sep 2021
Researchers have used artificial intelligence (AI) to predict the oxygen needs of COVID-19 patients on a global scale.

Addenbrooke’s Hospital (Cambridge, England) along with 20 other hospitals from across the world and AI technology company NVIDIA (Santa Clara, CA, USA) have built an AI tool to predict how much extra oxygen a COVID-19 patient may need in the first days of hospital care, using data from across four continents. More...
The technique, known as federated learning, used an algorithm to analyze chest X-rays and electronic health data from hospital patients with symptoms of COVID-19.

To maintain strict patient confidentiality, the patient data was fully anonymized and an algorithm was sent to each hospital so no data was shared or left its location. Once the algorithm had ‘learned’ from the data, the analysis was brought together to build an AI tool which could predict the oxygen needs of hospitalized COVID-19 patients anywhere in the world. The study dubbed EXAM (for EMR CXR AI Model), was one of the largest, most diverse clinical federated learning studies to date. To check the accuracy of EXAM, it was tested out in a number of hospitals across five continents. The outcomes of around 10,000 COVID patients from across the world were analyzed in the study. The results showed it predicted the oxygen needed within 24 hours of a patient’s arrival in the emergency department, with a sensitivity of 95% and a specificity of over 88%.

“Federated learning has transformative power to bring AI innovation to the clinical workflow,” said Professor Fiona Gilbert, who led the study. “Our continued work with EXAM demonstrates that these kinds of global collaborations are repeatable and more efficient, so that we can meet clinicians’ needs to tackle complex health challenges and future epidemics.”

“Usually in AI development, when you create an algorithm on one hospital’s data, it doesn’t work well at any other hospital,” said Dr. Ittai Dayan, first author on the study. “By developing the EXAM model using federated learning and objective, multimodal data from different continents, we were able to build a generalizable model that can help frontline physicians worldwide.”

Related Links:
Addenbrooke’s Hospital
NVIDIA



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mobile X-Ray System
K4W
Radiation Safety Barrier
RayShield Intensi-Barrier
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.